We are live on ! Find out more
GMED icon

Globus Medical

259 hedge funds and large institutions have $2.88B invested in Globus Medical in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 100 increasing their positions, 84 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 84

1.14% more ownership

Funds ownership: 87.67%88.81% (+1.1%)

4% less funds holding

Funds holding: 269259 (-10)

13% less capital invested

Capital invested by funds: $3.3B → $2.88B (-$420M)

17% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 41

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

81% less call options, than puts

Call options by funds: $3.42M | Put options by funds: $17.8M

Holders
259
Holders Change
-10
Holders Change %
-3.72%
% of All Funds
5.63%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
34
Increased
100
Reduced
84
Closed
41
Calls
$3.42M
Puts
$17.8M
Net Calls
-$14.4M
Net Calls Change
-$14.3M
Name Holding Trade Value Shares
Change
Change in
Stake
PMFA
251
Plante Moran Financial Advisors
Michigan
$3K -$8.69K -200 -72%
AOWM
252
Alpha Omega Wealth Management
Virginia
$2K
PCG
253
Private Capital Group
Connecticut
$2K +$1.39K +32 New
CFGS
254
Concourse Financial Group Securities
Alabama
$1K
TFA
255
Toth Financial Advisory
Virginia
$1K
RCG
256
Ruggie Capital Group
Florida
$1K +$1.52K +35 New
CFA
257
Carroll Financial Associates
North Carolina
$1K +$1.65K +38 New
GEA
258
Glen Eagle Advisors
New Jersey
$423
GT
259
Glenmede Trust
Pennsylvania
$215 -$86K -1,980 -28%
Victory Capital Management
260
Victory Capital Management
Texas
-$45.6M -922,855 Closed
Point72 Asset Management
261
Point72 Asset Management
Connecticut
-$24M -485,330 Closed
RHJA
262
Rice Hall James & Associates
California
-$15.4M -311,342 Closed
MFIMFI
263
Mesirow Financial Investment Management - Fixed Income
Illinois
-$5.84M -118,175 Closed
FLAM
264
First Light Asset Management
Minnesota
-$5.11M -103,356 Closed
Arrowstreet Capital
265
Arrowstreet Capital
Massachusetts
-$4.85M -98,073 Closed
AIM
266
Assured Investment Management
New York
-$4.13M -83,532 Closed
PVI
267
Pura Vida Investments
New York
-$3.47M -80,000 Closed
N
268
Natixis
France
-$3.52M -72,449 Closed
Millennium Management
269
Millennium Management
New York
-$2.31M -53,264 Closed
BG
270
Bahl & Gaynor
Ohio
-$1.88M -38,069 Closed
GCP
271
GSA Capital Partners
United Kingdom
-$1.24M -25,095 Closed
First Trust Advisors
272
First Trust Advisors
Illinois
-$1.06M -21,545 Closed
Mitsubishi UFJ Trust & Banking
273
Mitsubishi UFJ Trust & Banking
Japan
-$763K -15,439 Closed
Tudor Investment Corp
274
Tudor Investment Corp
Connecticut
-$645K -13,059 Closed
PCM
275
Prelude Capital Management
New York
-$561K -11,348 Closed

GMED Hedge Fund Activity: Q2 2019 in Review

259 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2019, worth a combined $2.88B — down 13% from $3.3B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of GMED and 34 opened new positions — a net loss of 7 holders — while 84 trimmed existing stakes and 100 added.

The largest buyer was Janus Henderson Group, adding an estimated $122M. The largest seller was Victory Capital Management, exiting entirely with an estimated $45.6M sold.

  • 259 institutional investors held Globus Medical (GMED) as of Q2 2019, down from 269 in Q1 2019.
  • Funds reported $2.88B of Globus Medical stock for Q2 2019, down 13% quarter-over-quarter.
  • 34 funds opened new Globus Medical positions in Q2 2019 and 41 closed out, a net change of -7 holders.
  • The largest Globus Medical buyer in Q2 2019 was Janus Henderson Group, an estimated $122M added.
  • The largest Globus Medical seller in Q2 2019 was Victory Capital Management, an estimated $45.6M sold.

Based on aggregated 13F filings for Q2 2019.